ei ole lubatud
ei ole lubatud
Digitaalõiguste kaitse (DRM)
Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).
Vajalik tarkvara
Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)
PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )
Seda e-raamatut ei saa lugeda Amazon Kindle's.
Section 1 Drug safety-related issues
1. Introduction: Why do we need a book on drug safety in developing countries?
2. Medications safety-related terminology
3. Medications registration and marketing: safety-related issues
4. Pharmacovigilance
5. Adverse drug reactions
6. Medication errors
7. Self-medication
8. Antibiotics safety issue
9. Drug-related problems
10. Counterfeit and substandard medications
11. Medication abuse and misuse
12. Storage and disposal of medications
13. Safety of medications in special population
14. Herbal medicines safety issues
15. Medications safety resources and tools
16. Medications safety pharmacoeconomics-related issues
17. Evidence-based medications safety practice
18. Technology in medications safety
19. Medications safety research issues
20. Quality indicators for medications safety
Section 2: Drug Safety in Asia 21. Drug safety in Malaysia
22. Drug safety in Thailand
23. Drug safety in Indonesia
24. Drug safety in Pakistan
25. Drug safety in India
26. Drug safety in Nepal
27. Drug safety in Sri Lanka
28. Drug Safety in China
Section 3: Drug Safety in Middle East 29. Drug safety in Yemen
30. Drug safety in Saudi Arabia
31. Drug safety in UAE
32. Drug safety in Jordan
33. Drug safety in Lebanon
34. Drug safety in Palestine
35. Drug safety in Qatar
Section 4: Drug Safety in Africa
36. Drug safety in Sudan
37. Drug safety in Egypt
38. Drug safety in Nigeria
39. Drug safety in Mali
40. Drug safety in Burkina Faso
Section 5: Drug Safety in Latin America 41. Drug safety in Chile
Section 6: Comparisons and conclusions
42. Compare between the developing countries
43. Drug Safety in Developing Versus Developed countries